101 related articles for article (PubMed ID: 12417792)
1. Postoperative hyperprolactinemia could predict longer disease-free and overall survival in node-negative breast cancer patients.
Mandalà M; Lissoni P; Ferretti G; Rocca A; Torri V; Moro C; Curigliano G; Barni S
Oncology; 2002; 63(4):370-7. PubMed ID: 12417792
[TBL] [Abstract][Full Text] [Related]
2. Prediction of recurrence in operable breast cancer by postoperative changes in prolactin secretion.
Lissoni P; Barni S; Cazzaniga M; Ardizzoia A; Rovelli F; Tancini G; Brivio F; Frigerio F
Oncology; 1995; 52(6):439-42. PubMed ID: 7478427
[TBL] [Abstract][Full Text] [Related]
3. HER2 expression in breast cancer: correlation with endocrine function and psychological status in operable and metastatic breast cancer.
Lissoni P; Messina G; Rovelli F; Brivio F; Fumagalli L; Villa S; Bartolacelli E
In Vivo; 2009; 23(6):987-9. PubMed ID: 20023245
[TBL] [Abstract][Full Text] [Related]
4. Node negative breast carcinoma: hyperprolactinemia and/or overexpression of p53 as an independent predictor of poor prognosis compared to newer and established prognosticators.
Patel DD; Bhatavdekar JM; Chikhlikar PR; Ghosh N; Suthar TP; Shah NG; Mehta RH; Balar DB
J Surg Oncol; 1996 Jun; 62(2):86-92. PubMed ID: 8649046
[TBL] [Abstract][Full Text] [Related]
5. The favorable prognostic significance of surgery-induced hyperprolactinemia in node-positive breast cancer patients: ten-year disease-free survival results.
Bignami A; Lissoni P; Brivio F; Galbiati F; Pescia S; Messina G; Frontini L; Meregalli S; Gardani GS
Int J Biol Markers; 2005; 20(1):60-4. PubMed ID: 15832774
[TBL] [Abstract][Full Text] [Related]
6. Effects of radical mastectomy on prolactin blood levels in patients with breast cancer.
Barni S; Lissoni P; Paolorossi F; Crispino S; Rovelli F; Ferri L; Sormani A; D'Alonso U; Bugatti A; Nociti V
Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1141-5. PubMed ID: 3653210
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of insulin-like growth factor-I in operable breast cancer in relation to the main prognostic variables and their perioperative changes in relation to those of prolactin.
Barni S; Lissoni P; Brivio F; Fumagalli L; Merlini D; Cataldo M; Rovelli F; Tancini G
Tumori; 1994 Jun; 80(3):212-5. PubMed ID: 8053079
[TBL] [Abstract][Full Text] [Related]
8. Relation between surgery-induced prolactin increase and the menstrual cycle phase at time of surgery in premenopausal breast cancer.
Barni S; Lissoni P; Mandelli D; Archili C; Real G; Sormani AL; Caprotti R; Tancini G
Int J Biol Markers; 1991; 6(2):103-6. PubMed ID: 1890313
[TBL] [Abstract][Full Text] [Related]
9. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
[TBL] [Abstract][Full Text] [Related]
10. A study of surgical psychoncology in breast cancer: perioperative variation of prolactin serum levels in women with operable breast cancer in relation to their maternal psychological behaviour.
Messina G; Lissoni P; Brivio F; Rovelli F; Fumagalli L; Bartolacelli E; Mazza U; Colombo E; Bertoglio A
In Vivo; 2008; 22(6):845-8. PubMed ID: 19181018
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer recurrence after immediate reconstruction: patterns and significance.
Langstein HN; Cheng MH; Singletary SE; Robb GL; Hoy E; Smith TL; Kroll SS
Plast Reconstr Surg; 2003 Feb; 111(2):712-20; discussion 721-2. PubMed ID: 12560692
[TBL] [Abstract][Full Text] [Related]
12. Time interval from breast-conserving surgery to breast irradiation in early stage node-negative breast cancer: 17-year follow-up results and patterns of recurrence.
Vujovic O; Yu E; Cherian A; Dar AR; Stitt L; Perera F
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):319-24. PubMed ID: 25636757
[TBL] [Abstract][Full Text] [Related]
13. Prolactin serum level in patients with breast cancer.
Cohen AD; Cohen Y; Maislos M; Buskila D
Isr Med Assoc J; 2000 Apr; 2(4):287-9. PubMed ID: 10804904
[TBL] [Abstract][Full Text] [Related]
14. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.
Truong PT; Olivotto IA; Speers CH; Wai ES; Berthelet E; Kader HA
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):797-804. PubMed ID: 14967436
[TBL] [Abstract][Full Text] [Related]
15. Preoperative breast MRI for early-stage breast cancer: effect on surgical and long-term outcomes.
Sung JS; Li J; Da Costa G; Patil S; Van Zee KJ; Dershaw DD; Morris EA
AJR Am J Roentgenol; 2014 Jun; 202(6):1376-82. PubMed ID: 24848838
[TBL] [Abstract][Full Text] [Related]
16. Waiting time for radiation therapy after breast-conserving surgery in early breast cancer: a retrospective analysis of local relapse and distant metastases in 615 patients.
Caponio R; Ciliberti MP; Graziano G; Necchia R; Scognamillo G; Pascali A; Bonaduce S; Milella A; Matichecchia G; Cristofaro C; Di Fatta D; Tamborra P; Lioce M
Eur J Med Res; 2016 Aug; 21(1):32. PubMed ID: 27514645
[TBL] [Abstract][Full Text] [Related]
17. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
[TBL] [Abstract][Full Text] [Related]
18. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
19. Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.
Foukakis T; von Minckwitz G; Bengtsson NO; Brandberg Y; Wallberg B; Fornander T; Mlineritsch B; Schmatloch S; Singer CF; Steger G; Egle D; Karlsson E; Carlsson L; Loibl S; Untch M; Hellström M; Johansson H; Anderson H; Malmström P; Gnant M; Greil R; Möbus V; Bergh J;
JAMA; 2016 Nov; 316(18):1888-1896. PubMed ID: 27825007
[TBL] [Abstract][Full Text] [Related]
20. Prolactin as a local growth promoter in patients with breast cancer: GCRI experience.
Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Ghosh N; Chikhlikar PR; Trivedi TI
Eur J Surg Oncol; 2000 Sep; 26(6):540-7. PubMed ID: 11034803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
